Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2089106 | 0.80 | ALDH1A1 (0.31) | ALDH1A1POLBTDP1L3MBTL1TSHR | |
| SCHEMBL67468 | 0.79 | ALDH1A1 (0.43) | ALDH1A1POLBTDP1L3MBTL1TSHR | |
| SCHEMBL18242624 | 0.76 | ELANE (0.32) | — | |
| SCHEMBL1119408 | 0.75 | MAPT (0.31) | — | |
| SCHEMBL1119514 | 0.73 | LMNA (0.32) | — | |
| SCHEMBL3159144 | 0.71 | IDO1 (0.31) | — | |
| SCHEMBL5250573 | 0.70 | — | — | |
| SCHEMBL8607372 | 0.70 | ALDH1A1 (0.52) | ALDH1A1POLBTDP1L3MBTL1TSHR | |
| SCHEMBL6286508 | 0.70 | ALDH1A1 (0.31) | ALDH1A1POLBTDP1L3MBTL1TSHR | |
| SCHEMBL3162553 | 0.70 | P2RX7 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012142670-A1 | NUCLEAR MAGNETIC RESONANCE AGENT | THE UNIVERSITY OF QUEENSLAND (AU) | 2012-10-26 | — | — | WO | claimed |
| WO-2003045441-A1 | CONTRAST AGENTS FOR THE IN VIVO DETECTION OF ENZYME ACTIVITY | AMERSHAM HEALTH AS (NO) | 2003-06-05 | — | — | WO | claimed |
| WO-2012142670-A1 | NUCLEAR MAGNETIC RESONANCE AGENT | THE UNIVERSITY OF QUEENSLAND (AU) | 2012-10-26 | — | — | WO | disclosed |
| EP-1465669-B1 | METAL COMPLEX COMPOUNDS | GE HEALTHCARE AS (NO) | 2007-10-24 | — | — | EP | disclosed |
| US-7198776-B2 | Metal complex compounds | GE HEALTHCARE AS (NO) | 2007-04-03 | — | — | US | disclosed |
| US-20050090653-A1 | Metal complex compounds | GE HEALTHCARE AS (NO) | 2005-04-28 | — | — | US | disclosed |
| EP-1465669-A1 | METAL COMPLEX COMPOUNDS | Amersham Health AS (NO) | 2004-10-13 | — | — | EP | disclosed |
| WO-2003045442-A1 | METAL COMPLEX COMPOUNDS | AMERSHAM HEALTH AS (NO) | 2003-06-05 | — | — | WO | disclosed |
| WO-2003045441-A1 | CONTRAST AGENTS FOR THE IN VIVO DETECTION OF ENZYME ACTIVITY | AMERSHAM HEALTH AS (NO) | 2003-06-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050090653-A1 | Metal complex compounds | ME3, MPI, ME2 | ALDH1A1 2723/4885POLB 2143/4885TDP1 1967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.